Picture of Kezar Life Sciences logo

KZR — Kezar Life Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Kezar Life Sciences Q3 Operating Expenses USD 21.948 Million

Nov 12 (Reuters) - Kezar Life Sciences Q3 operating income USD -21.948
million.
* Q3 net income USD -20.313 million vs. IBES estimate USD -22.6 million

Recent news on Kezar Life Sciences

See all news